Glycosaminoglycans are part of amyloid fibrils: Ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold

Amyloid

Volumn 13, Issue 1, 2006, Pages 13-19

  Gruys, E ^a,b   Ultee, A ^a   Upragarin, N ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Faculty of Veterinary Medicine   (Netherlands)

Author keywords

Amyloid fibril; Glycoprotein; Glycosaminoglycan; Immunogold labeling; Proteoglycan

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; COLLAGEN FIBRIL; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; CHICKEN; FOWL; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; LIVER; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

AMYLOID; AMYLOIDOSIS; ANIMALS; CHICKENS; GLYCOSAMINOGLYCANS; IMMUNOHISTOCHEMISTRY; INDOLES; MICROSCOPY, ELECTRON, TRANSMISSION; ORGANOMETALLIC COMPOUNDS; STAINING AND LABELING;

EID: 33646760586     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500535768     Document Type: Article

References (61)

1. Friedreich N, Kekulé A. Zur Amyloidfrage. Virchows Arch Pathol Anat Physiol 1859;16:50-65.
2. Kazatchkine D. Nomenclature of amyloid and amyloidosis. Bull WHO 1993;71:105-108.
3. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD. Amyloid fibril protein nomenclature - 2002. Amyloid. J Prot Fold Disord 2002;9:197-200.
4. Glenner GG. Amyloid deposits and amyloidosis. The beta-fibrilloses. New Engl J Med 1980;302:1283-1292, 1333-1343.
5. Stevens FJ. Amyloid formation: an emulation of matrix protein assembly? Amyloid J Prot Fold Disord 2004;11:232-244.
6. Sasai Y, Nagata M, Inokuchi K, Namba K. Histochemical investigation of acid mucopolysacharides in amyloid, colloid and hyaline. Acta Histochem 1978;62:223-236.
7. Linker A, Carney HC. Presence and role of glycosaminoglycans in amyloidosis. Lab Invest 1987;57:297-305.
8. Snow AD, Willmer J, Kisilevsky R. Sulfated glycosaminoglycans: a common constituent of all amyloids? Lab Invest 1987;56:120-123.
9. Snow AD, Kisilevsky R, Stephens C, Anastassiades T. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 1987;56:665-675.
10. Snow AD, Willmer J, Kisilevsky R. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. Lab Invest 1987;57:687-698.
11. Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, DeArmond SJ, Prusiner SB. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest 1990;63:601-611.
12. Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 1991;39:1321-1330.
13. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 1994;12:219-234.
14. Kisilevsky R, Snow A. The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or perhaps amyloid is not a misnomer. Med Hypoth 1988; 26:231-236.
15. Linker A. Proteoglycans in the pathogenesis of amyloidosis. Neurobiol Aging 1989;10:507-508.
16. Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A, Cohen AS, Schmid K. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver and spleen. Clin Chem 1990;36:88-91.
17. Guiroy DC, Yanagihara R, Gajdusek DC. Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol 1991;82:87-92.
18. Nelson SR, Lyon M, Gallacher JT, Johnson EA, Pepys MB. Isolation and characterization of the integral glycosaminoglycan constituent of human amyloid A and monoclonal light-chain amyloid fibrils. Biochem J 1991;275:67-73.
19. Stenstad T, Magnus JH, Kolset SO, Cornwell GG, Husby G. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin. Scand J Immunol 1991;34:611-617.
20. Stenstad T, Magnus JH, Syse K, Husby G. On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component. Clin Exp Immunol 1993;94:189-195.
21. Stenstad T, Magnus JH, Husby G. Characterization of proteoglycans associated with mouse splenic AA amyloidosis. Biochem J 1994;303:663-670.
22. Magnus JH. Isolation and characterization of amyloid associated glycosaminoglycans and proteoglycans from human tissues. 1991; PhD thesis, Tromso.
23. Magnus JH, Stenstad T, Kolset SO, Husby G. Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111. Scand J Immunol 1991;34: 63-69.
24. Magnus JH, Kolset SO, Husby G. High molecular weight glycosaminoglycans in AA type amyloid fibril extracts from human liver. Ann Rheum Dis 1991;50:562-566.
25. Magnus JH, Stenstad, Husby G, Kolset SO. Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid. Biochem J 1992;288: 225-231.
26. Lyon AW, Narindrasorak S, Young ID, Anastassiades T, Couchman JR, McCarthy KJ, Kisilevsky R. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab Invest 1991;64:785-790.
27. Athanasou NA, West L, Sallie B, Puddle B. Localized amyloid deposition in cartilage is glycosaminoglycan-associated. Histopathology 1995;26:267-272.
28. Narindrasorak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggest a role in the pathogenesis of Alzheimer's disease. Lab Invest 1995;72:272-282.
29. Ohashi K, Hara M, Yanagishita M, Kawai R, Tachibana S, Ogura Y. Proteoglycans in haemodialysis-related amyloidosis. Virchows Arch 1995;427:49-59.
30. Magnus JH, Stenstad T. Proteoglycans and the extracellular matrix in amyloidosis. Amyloid Int J Exp Clin Invest 1997;4:121-134.
31. Snow AD, Castillo GM. Specific proteoglycans as potential causative agents and relevant targets for therapeutic intervention in Alzheimer's disease and other amyloidoses. Amyloid Int J Exp Clin Invest 1997;4:135-141.
32. Niewold TA, Flores Landeira JM, van den Heuvel LP, Ultee A, Tooten PC, Veerkamp JH. Characterization of proteoglycans. Virchows Arch B 1990;60:321-328.
33. Wien TN, Omstvedt LA, Landsverk T, Husby G. Characterization of proteglycans and glycosaminoglycans in splenic AA amyloid induced in mink. Scan J Immunol 2000;52:576-583.
34. Wien TN, Sorby R, Omtvedt LA, Landsverk T, Husby G. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink. Scand J Immunol. 2004;60: 600-608, with erratum in Scan J Immunol 2005;61: 215.
35. Jiang X, Myatt E, Lykos P, Stevens FJ. Interaction between glycosaminoglycans and immunoglobulin light chains. Biochemistry 1997;36:13187-13194.
36. Castillo GM, Cummings JA, Yang W, Judge ME, Sheardown MJ, Rimvall K, Hansen JB, Snow AD. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 1998;47: 612-620.
37. Castillo GM, Lukito W, Wight TN, Snow AD. The sulphate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J Neurochem 1999;72:1681-1687.
38. Fraser PE, Darabie AA, McLaurin JA. Amyloid-beta interactions with chondroitin sulphate-derived monosaccharides and disaccharides. Implications for drug development. J Biol Chem 2001;276:6412-6419.
39. Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian Blue in salt solutions. Histochemistry 1965;5:221-233.
40. Van Kuppevelt THMSM, Cremers FRM, Domen JGW, Kuyper CMA. Staining of proteoglycans in mouse lung alveoli. II Characterization of cuprolinic blue-positive, anionic sites. Histochem J 1984;16:671-686.
41. Inoue S, Kisilevsky R. A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 1996;74: 670-683.
42. Inoue S, Kuroiwa M, Kisilevsky R. AA protein in experimental murine AA amyloid fibrils: a high resolution ultrastructural and immunohistochemical study comparing aldehyde-fixed and cryofixed tissues. Amyloid J Prot Fold Disord 2002;9:115-125.
43. Inoue S, Ohashi K, Saraiva M, Kisilevsky R. A novel organization of in-situ amyloid fibrils as established with high resolution electronmicroscopy. In: Kyle RA, Gertz MA, editors. Amyloid and amyloidosis, The proceedings of the VIIIth international symposium on amyloidosis, August 1998. New York: Parthenon; 1999. pp 80-82.
44. Inoue S, Kuroiwa M, Kisilevsky R. Basement membranes, microfibrils and beta amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings. Brain Res Rev 1999;29:218-231.
45. Inoue S, Kuroiwa M, Tan R, Kisilevsky R. A high resolution ultrastructural comparison of isolated and in situ murine AA amyloid fibrils. Amyloid Int J Exp Clin Invest 1998;5: 99-110.
46. Inoue S. Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye both in vivo and in vitro. Cell Tissue Res 1995;279:291-302.
47. Peperkamp NHMT, Landman WJM, Tooten PCJ, Ultee A, Voorhout WF, Gruys E. Light microscopic, immunohistochemical and electron microscopical features of amyloid arthropathy in chickens. Vet Pathol 1997;34:271-278.
48. Gruys E, Snel FWJJ. Animal models for reactive amyloidosis. Bailliere's Clinical Rheumatology 1994;8:599-611.
49. Landman WJM, Gruys E, Dwars RM. A syndrome associated with growth depression and amyloid arthropathy in layers: a preliminary report. Avian Pathol 1994;23:461-470.
50. Landman WJM. Amyloid arthropathy in chickens. PhD thesis, Utrecht, 1998.
51. Landman WJM, Peperkamp NHMT, Koch CAM, Tooten PCJ, Crauwels PAP, Gruys E. Induction of amyloid arthropathy in chickens. Amyloid Int J Exp Clin Invest 1997;4: 87-97.
52. Landman WJM, Sletten K, Koch CAM, Tooten PCJ, Gruys E. Chicken joint amyloid protein is of the AA-type. I. Characterization of the amyloid protein. Scand J Immunol 1996,43:210-218.
53. Linke RP, Nathrath WBJ, Wilson PD. Immuno-electron microscopic identification and classification of amyloid in tissue sections by the postembedding protein-A gold method. Ultrastruct Pathol 1983,4:1-7.
54. Chronopoulos S, Chan SL, Ratcliffe MJH, AliKhan Z. Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: a double immunogold electron microscopic study. Amyloid Int J Exp Clin Invest 1995,2:191-194.
55. Van Garderen E, de Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H, Misdorp W. Expression of growth hormone in canine mammary tissue and mammary tumors. Am J Pathol 1997;150:1037-1047.
56. Fukuchi K, Hart M, Li L. Alzheimer's disease and heparan sulfate proteoglycan. Front Biosci 1998;3:327-337.
57. Ancsin JB. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid J Prot Fold Disord 2003;10:67-79.
58. Virchow R. Zur Cellulose-Frage. Virchows Arch Pathol Anat Physiol Klin Med 1854;6:416-426.
59. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, Szarek WA. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1995;1:143-148.
60. Gervais F, Chalifour R, Garceau D, Kong X, Laurin J, McLaughlin R, Morisette C, Paquette J. Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy. Amyloid J Prot Fold Disord 2001;8,Suppl 1: 28-35.
61. Inoue S, Hultin PG, Szarek WA, Kisilevsky R. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study. Lab Invest 1996;74:1081-1090.